osimertinib mesylate
Term · Oncology and biomedicine · MLC-T-ONC-006167
A drug used alone or with other drugs to treat adults with certain types of non-small cell lung cancer that have an abnormal EGFR gene. It is also being studied in the treatment of other types of cancer. Osimertinib mesylate blocks certain proteins made by the mutated EGFR gene, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called Tagrisso.
| Identifier | MLC-T-ONC-006167 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Tagrisso |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006167",
"term": "osimertinib mesylate",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with other drugs to treat adults with certain types of non-small cell lung cancer that have an abnormal EGFR gene. It is also being studied in the treatment of other types of cancer. Osimertinib mesylate blocks certain proteins made by the mutated EGFR gene, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called Tagrisso.",
"synonyms": [
"Tagrisso"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/osimertinib-mesylate/"
}
Record 12,376 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.